3-羟基苯甲酰胺 | 618-49-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-羟基苯甲酰胺
• 英文名称: 3-hydroxybenzamide
• 英文别名: m-hydroxybenzamide
• CAS: 618-49-5
• 化学式: C₇H₇NO₂
• mdl: MFCD00017572
• 分子量: 137.138
• InChiKey: NGMMGKYJUWYIIG-UHFFFAOYSA-N

物化性质

• 熔点：
  170 °C
• 沸点：
  318.3±25.0 °C(Predicted)
• 密度：
  1.449 g/cm3
• 溶解度：
  溶于甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Hydroxybenzamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H319: Causes serious eye irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Hydroxybenzamide
CAS number: 618-49-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H7NO2
Molecular weight: 137.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-羟基苯甲酰胺 275.0 ℃ 、100.0 kPa 条件下， 反应 10.0h， 生成 3-氰基苯酚
  参考文献：
  名称：

  气相脱水制备腈的方法

  摘要：

  本发明公开了一种气相脱水制备腈的方法，即：在脱水催化剂存在下，在管式反应器中，酰胺发生气相脱水反应，得到腈，其中脱水催化剂为本体催化剂或者负载型催化剂。本发明采用脱水催化剂技术，解决了传统的酰胺脱水需要大量脱水剂、产生大量废物的技术难题。该路线不但单程产率高，而且易于连续工业化，具有环保、绿色、节能的特点。

  公开号：

  CN114057605A
• 作为产物：
  描述：

  3-甲氧基苯甲酰胺 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 生成 3-羟基苯甲酰胺
  参考文献：
  名称：

  Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ

  摘要：

  3-Methoxybenzamide is a weak inhibitor of the essential bacterial cell division protein FtsZ. Exploration of the structure-activity relationships of 3-methoxybenzamide analogues led to the identification of potent anti-staphylococcal compounds. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.11.021

文献信息

• [EN] PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF<br/>[FR] INHIBITEURS DE LA PRMT5 CONTENANT UNE DIHYDRO- OU TÉTRAHYDRO-ISOQUINOLÉINE ET LEURS UTILISATIONS
  申请人：EPIZYME INC

  公开号：WO2014100730A1

  公开（公告）日：2014-06-26

  Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.

  本文描述了式（A）的化合物，其药学上可接受的盐以及药物组合物。本发明的化合物对抑制PRMT5活性是有用的。还描述了利用这些化合物治疗PRMT5介导的疾病的方法。
• PRMT5 INHIBITORS AND USES THEREOF
  申请人：Duncan Kenneth W.

  公开号：US20190083482A1

  公开（公告）日：2019-03-21

  Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.

  本文描述了式（I）的化合物，其药学上可接受的盐以及药物组合物。本发明的化合物对抑制PRMT5活性是有用的。还描述了利用这些化合物治疗PRMT5介导的疾病的方法。
• Transamidation for the Synthesis of Primary Amides at Room Temperature
  作者：Jiajia Chen、Yuanzhi Xia、Sunwoo Lee

  DOI：10.1021/acs.orglett.0c00958

  日期：2020.5.1

  Various primary amides have been synthesized using the transamidation of various tertiary amides under metal-free and mild reaction conditions. When (NH4)2CO3 reacts with a tertiary amide bearing an N-electron-withdrawing substituent, such as sulfonyl and diacyl, in DMSO at 25 °C, the desired primary amide product is formed in good yield with good funcctional group tolerance. In addition, N-tosylated

  在无金属和温和的反应条件下，使用各种叔酰胺进行转酰胺作用，可以合成出各种伯酰胺。当（NH4）2CO3在25°C的DMSO中与带有N吸电子取代基的叔酰胺（如磺酰基和二酰基）反应时，可以形成具有良好官能团耐受性的高收率的所需伯酰胺产物。另外，N-甲苯磺酸化的内酰胺衍生物通过开环反应提供了它们相应的N-甲苯磺酰胺基烷基酰胺产物。
• Development of a Simple and Efficient Solution-Phase Parallel Synthesis of Flexible Non-Steroidal Estradiol Mimics
  作者：Guy Djigoue、Rene Maltais、Donald Poirier

  DOI：10.2174/1386207317666140915125620

  日期：2014.11.7

  An efficient parallel synthesis was designed to provide libraries of estradiol mimics that can potentially interact with different biological targets associated with estradiol-related diseases. Two libraries of 75 members each were synthesized around a non-steroidal core by adding three levels of molecular diversity. Hydroxybenzaldehydes (1st level of diversity), protected as a methoxymethyl ether

  设计了一种有效的平行合成方法，以提供可能与与雌二醇相关疾病相关的不同生物靶标相互作用的雌二醇模拟物文库。通过添加三个水平的分子多样性，围绕非甾体核心合成了两个75个成员的文库。被保护为甲氧基甲基醚的羟基苯甲醛（第1级多样性）在还原胺化条件下首先与伯胺（第2级多样性）反应。接下来，所得仲胺与4-溴-1,2-环氧丁烷反应，以提供作为第三级多样性的前体的环氧化物衍生物。然后使用各种亲核试剂打开每个环氧化物。
• [EN] ANTIMICROBIAL AGENTS<br/>[FR] AGENTS ANTIMICROBIENS
  申请人：UNIV RUTGERS

  公开号：WO2014074932A1

  公开（公告）日：2014-05-15

  The invention provides compounds of formula (I): wherein R1-R3, n, and W have any of the values defined in the specification, and salts thereof. The compounds have good solubility and are useful for treating bacterial infections.

  该发明提供了式（I）的化合物：其中R1-R3，n和W具有规范中定义的任何值，以及其盐。这些化合物具有良好的溶解性，并可用于治疗细菌感染。

表征谱图